JP2024513559A5 - - Google Patents
Info
- Publication number
- JP2024513559A5 JP2024513559A5 JP2023561342A JP2023561342A JP2024513559A5 JP 2024513559 A5 JP2024513559 A5 JP 2024513559A5 JP 2023561342 A JP2023561342 A JP 2023561342A JP 2023561342 A JP2023561342 A JP 2023561342A JP 2024513559 A5 JP2024513559 A5 JP 2024513559A5
- Authority
- JP
- Japan
- Prior art keywords
- repeat domain
- ankyrin repeat
- human
- binding
- binding specificity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163173186P | 2021-04-09 | 2021-04-09 | |
| US202163172973P | 2021-04-09 | 2021-04-09 | |
| US63/173,186 | 2021-04-09 | ||
| US63/172,973 | 2021-04-09 | ||
| US202163265181P | 2021-12-09 | 2021-12-09 | |
| US63/265,181 | 2021-12-09 | ||
| PCT/IB2022/053275 WO2022215032A1 (en) | 2021-04-09 | 2022-04-07 | Novel darpin based cd70 engagers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513559A JP2024513559A (ja) | 2024-03-26 |
| JP2024513559A5 true JP2024513559A5 (cg-RX-API-DMAC7.html) | 2025-04-03 |
Family
ID=81386901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561342A Pending JP2024513559A (ja) | 2021-04-09 | 2022-04-07 | 新規なDARPinベースのCD70エンゲージャー |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250074994A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4319883A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024513559A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230169182A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022252985A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023020685A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3214020A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023011978A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022215032A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298168A (en) | 2020-05-14 | 2023-01-01 | Molecular Partners Ag | Multispecific proteins |
| WO2022190016A1 (en) | 2021-03-09 | 2022-09-15 | Molecular Partners Ag | Novel darpin based multi-specific t-cell engagers |
| WO2024251628A1 (en) * | 2023-06-06 | 2024-12-12 | Molecular Partners Ag | Recombinant cd16a binding proteins and their use |
| JP2026524079A (ja) | 2023-06-06 | 2026-07-17 | モレキュラー パートナーズ アクチェンゲゼルシャフト | 組換えcd2結合タンパク質及びその使用 |
| WO2025181039A1 (en) | 2024-03-01 | 2025-09-04 | Molecular Partners Ag | Therapeutic combinations comprising a multi-specific t cell engager |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100150950A1 (en) * | 2006-12-14 | 2010-06-17 | Medarex, Inc. | Human antibodies that bind cd70 and uses thereof |
| EP3974453A3 (en) * | 2010-11-16 | 2022-08-03 | Amgen Inc. | Agents and methods for treating diseases that correlate with bcma expression |
| EP3514169B1 (en) * | 2010-11-26 | 2024-03-06 | Molecular Partners AG | Designed repeat proteins binding to serum albumin |
| JP2016531920A (ja) * | 2013-09-05 | 2016-10-13 | アデュロ・バイオテック・ホールディングス・ヨーロッパ・ベスローテン・フエンノートシャップAduro Biotech Holdings, Europe B.V. | Cd70結合ペプチドおよびそれに関連する方法、プロセスおよび用途 |
| US9458211B1 (en) * | 2015-04-02 | 2016-10-04 | Molecular Partners Ag | Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains |
| US11291721B2 (en) * | 2016-03-21 | 2022-04-05 | Marengo Therapeutics, Inc. | Multispecific and multifunctional molecules and uses thereof |
| MX2020008183A (es) * | 2018-02-01 | 2020-09-22 | Pfizer | Anticuerpos especificos para cd70 y sus usos. |
| TW202010757A (zh) * | 2018-04-11 | 2020-03-16 | 美商英伊布里克斯公司 | 具有經受限cd3結合的多重特異性多肽構築體以及相關方法及用途 |
| JP2022535564A (ja) * | 2019-06-04 | 2022-08-09 | モレキュラー パートナーズ アクチェンゲゼルシャフト | 多選択性タンパク質 |
| EP3980452A1 (en) * | 2019-06-04 | 2022-04-13 | Molecular Partners AG | Recombinant 4-1bb binding proteins and their use |
| WO2022190016A1 (en) * | 2021-03-09 | 2022-09-15 | Molecular Partners Ag | Novel darpin based multi-specific t-cell engagers |
-
2022
- 2022-04-07 KR KR1020237036653A patent/KR20230169182A/ko active Pending
- 2022-04-07 EP EP22719030.3A patent/EP4319883A1/en active Pending
- 2022-04-07 JP JP2023561342A patent/JP2024513559A/ja active Pending
- 2022-04-07 CA CA3214020A patent/CA3214020A1/en active Pending
- 2022-04-07 US US18/554,248 patent/US20250074994A1/en active Pending
- 2022-04-07 AU AU2022252985A patent/AU2022252985A1/en not_active Abandoned
- 2022-04-07 BR BR112023020685A patent/BR112023020685A2/pt not_active Application Discontinuation
- 2022-04-07 WO PCT/IB2022/053275 patent/WO2022215032A1/en not_active Ceased
- 2022-04-07 MX MX2023011978A patent/MX2023011978A/es unknown